The loss of miR-155 in MDSCs improved T-cell function and decreased Arg-1, iNOS, Vegf, and Mmp-9 expression, all of which are involved in immune suppression, tumor vascularization, and metastasis. This evidence concerns the gene NOS2 and neoplasm.